Patent details

EP3337828 Title: ANTI-PCSK9 INHIBITORY ANTIBODIES FOR TREATING PATIENTS WITH HYPERLIPIDEMIA UNDERGOING LIPOPROTEIN APHERESIS

Basic Information

Publication number:
EP3337828
PCT Application Number:
US2016047257
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP167580190
PCT Publication Number:
WO2017031151
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ANTI-PCSK9 INHIBITORY ANTIBODIES FOR TREATING PATIENTS WITH HYPERLIPIDEMIA UNDERGOING LIPOPROTEIN APHERESIS
French Title of Invention:
ANTICORPS INHIBITEURS ANTI-PCSK9 DESTINÉS AU TRAITEMENT DES PATIENTS ATTEINTS D'HYPERLIPIDÉMIE SUBISSANT UNE APHÉRÈSE DE LIPOPROTÉINES
German Title of Invention:
ANTI-PCSK9-HEMMERANTIKÖRPER ZUR BEHANDLUNG VON PATIENTEN MIT HYPERLIPIDÄMIE, DIE EINER LIPOPROTEINAPHERESE UNTERZOGEN WERDEN
SPC Number:

Dates

Filing date:
17/08/2016
Grant date:
27/08/2025
EP Publication Date:
27/06/2018
PCT Publication Date:
23/02/2017
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
27/08/2025
EP B1 Publication Date:
27/08/2025
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
17/08/2036
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
20/08/2025
 
 

Name:
Regeneron Pharmaceuticals, Inc.
Address:
777 Old Saw Mill River Road, Tarrytown, NY 10591, United States (US)

Inventor

1

Name:
PORDY, Robert C.
Address:
United States (US)

2

Name:
MANVELIAN, Garen
Address:
United States (US)

Priority

1

Priority Number:
201562206326 P
Priority Date:
18/08/2015
Priority Country:
United States (US)

2

Priority Number:
201562264361 P
Priority Date:
08/12/2015
Priority Country:
United States (US)

3

Priority Number:
201562270790 P
Priority Date:
22/12/2015
Priority Country:
United States (US)

4

Priority Number:
201662291571 P
Priority Date:
05/02/2016
Priority Country:
United States (US)

5

Priority Number:
201662311455 P
Priority Date:
22/03/2016
Priority Country:
United States (US)

6

Priority Number:
201662367374 P
Priority Date:
27/07/2016
Priority Country:
United States (US)

Classification

IPC classification:
C07K 16/40; A61P 3/06; A61K 39/395; A61K 39/00;

Publication

European Patent Bulletin

Issue number:
202535
Publication date:
27/08/2025
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
31/08/2026
Annual Fee Number:
11
Annual Fee Amount:
148 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages